LONG COVID19
Clinical trials for LONG COVID19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID19 trials appear
Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to get long COVID patients moving again
Symptom relief OngoingThis study tests different treatments to help people with Long COVID who have trouble exercising and feel very tired after activity. About 360 adults will be randomly assigned to a treatment or a control group. The main goal is to see if the treatments improve how long they can w…
Matched conditions: LONG COVID19
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 17, 2026 03:58 UTC
-
Could a diabetes drug shield the brain? early trial targets cognitive decline
Knowledge-focused TerminatedThis early-phase study looks at whether liraglutide (Saxenda®), a drug used for weight loss, can increase a brain-protective protein called BDNF in people with multiple sclerosis, long-COVID, or acute leukemia (in remission) who also have obesity and memory or thinking problems. …
Matched conditions: LONG COVID19
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC